Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae
Q Cheng1, D Finkel, M K Hostetter
1Yale Child Health Research Center, Yale University School of Medicine, 464 Congress Avenue, New Haven, Connecticut 06520-8081, USA.
Biochemistry
|May 23, 2000
Summary
Researchers identified a novel microbial protein from Streptococcus pneumoniae that binds complement component 3 (C3). This discovery offers new insights into bacterial evasion of host immune defenses.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Background:
- The complement system is crucial for host defense against microbial infections.
- Bacterial pathogens often possess mechanisms to evade complement-mediated immunity.
- Understanding microbial complement-binding proteins is key to developing new therapeutic strategies.
Purpose of the Study:
- To isolate and characterize microbial proteins that bind the third component of complement (C3).
- To identify the first C3-binding protein from Streptococcus pneumoniae.
- To investigate the functional and genetic properties of this novel protein.
Main Methods:
- Affinity chromatography using immobilized C3 to purify C3-binding proteins.
- Protein sequencing (amino-terminal and internal peptides).
- Gene isolation via PCR and genomic library screening.
- Analysis of protein structure and function in clinical isolates.
Main Results:
- Purification of a novel C3-binding protein from Streptococcus pneumoniae.
- Characterization of the protein's binding properties (noncovalent, C3 alpha-chain preferential).
- Identification of a proline-rich region, signal peptide, and choline-binding repeats within the protein.
- Demonstration of gene conservation and functional activity in clinical isolates.
- Detection of specific IgG antibodies against the protein in patient serum.
Conclusions:
- A novel choline-binding protein from Streptococcus pneumoniae binds C3, aiding immune evasion.
- The protein is conserved and elicits a host immune response.
- This protein represents a potential therapeutic target.
- The methodology can be applied to discover other microbial complement-binding proteins.
